Stock comparison
Align Technology
ALGN$12.42BHealthcare Market cap, Sector
Pro Medicus Limited
PME.AX$16.79BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
ALGN 07 PME.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ALGN0wins
7winsPME.AX
51D
B78
62C
A90
35F
A98
12F
A100
31F
B84
36F
A91
39F
A96
Side-by-side metrics
| Metric | ALGN | PME.AX |
|---|---|---|
| Market cap | $12.42B | $16.79B Winner |
| P/E (TTM) | Winner: 27.1x | 147.6x |
| EV/EBIT | Winner: 17.3x | 106.8x |
| ROIC (TTM) | 9.72% | 42.56% Winner |
| Gross margin | 67.68% | 99.85% Winner |
| Net margin | 10.5% | 54.12% Winner |
| Revenue CAGR 5y | 0.52% | 31.61% Winner |
| EPS CAGR 5y | -12.78% | 37.34% Winner |
| Debt / Equity | 0.0x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALGN leads on
- EV/EBIT17.3xvs 106.8x+84%
- P/E (TTM)27.1xvs 147.6x+82%
PME.AX leads on
- EPS CAGR 5y37.34%vs -12.78%+134%
- Revenue CAGR 5y31.61%vs 0.52%+98%
- Net margin54.12%vs 10.5%+81%
- ROIC (TTM)42.56%vs 9.72%+77%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.